CIP
NXTM

Convergence Investment Partners’s NxStage Medical Inc. NXTM Stock Holding History

Convergence Investment Partners’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-65,215
Closed -$1.63M – 402
2016
Q3 		$1.63M Buy
65,215
+44,545
+216% +$1.04M 0.24% 157
2016
Q2 		$448K Buy
+20,670
New +$369K 0.06% 283

Other funds holding NXTM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Convergence Investment Partners's NXTM Position: Q4 2016 in Review

Convergence Investment Partners sold out of NxStage Medical Inc. (NXTM) in Q4 2016, closing a stake of 65,215 shares — an estimated $1.63M sold.

Convergence Investment Partners first reported a position in NXTM in Q2 2016 and held it in 2 quarters. The position peaked at $1.63M in Q3 2016. 170 funds tracked by Wall St. Rank hold NXTM as of Q4 2016.

  • Convergence Investment Partners reported no remaining NxStage Medical Inc. position as of Q4 2016 after selling out during the quarter.
  • Convergence Investment Partners sold 65,215 NxStage Medical Inc. shares in Q4 2016, an estimated $1.63M.
  • Convergence Investment Partners first reported a position in NxStage Medical Inc. in Q2 2016 and held it in 2 quarters.
  • Convergence Investment Partners's NxStage Medical Inc. position peaked at $1.63M in Q3 2016.
  • 170 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2016.

Based on Convergence Investment Partners's 13F filing for Q4 2016, filed 13 Feb 2017.